Cell Metabolism
Volume 20, Issue 6, 2 December 2014, Pages 953-966
Journal home page for Cell Metabolism

Review
Metformin: From Mechanisms of Action to Therapies

https://doi.org/10.1016/j.cmet.2014.09.018Get rights and content
Under an Elsevier user license
open archive

Metformin is currently the first-line drug treatment for type 2 diabetes. Besides its glucose-lowering effect, there is interest in actions of the drug of potential relevance to cardiovascular diseases and cancer. However, the underlying mechanisms of action remain elusive. Convincing data place energy metabolism at the center of metformin’s mechanism of action in diabetes and may also be of importance in cardiovascular diseases and cancer. Metformin-induced activation of the energy-sensor AMPK is well documented, but may not account for all actions of the drug. Here, we summarize current knowledge about the different AMPK-dependent and AMPK-independent mechanisms underlying metformin action.

Cited by (0)